Are there any drug interactions between acenocoumarol (Acitrom) and metronidazole, ofloxacin, and ceftriaxone?

Significant Drug Interactions Between Acitrom and These Antibiotics

Yes, there are clinically significant interactions between acenocoumarol (Acitrom) and metronidazole, while ofloxacin carries moderate risk, and ceftriaxone has no direct anticoagulant interaction.

Metronidazole: HIGH RISK - Requires Dose Reduction

Metronidazole has a well-established, dangerous interaction with acenocoumarol that significantly increases bleeding risk 1, 2, 3. This occurs through two mechanisms:

• CYP2C9 inhibition: Metronidazole inhibits the enzyme that metabolizes acenocoumarol, causing drug accumulation
• Gut microbiome disruption: Reduces vitamin K production, further potentiating anticoagulation

Evidence-Based Management:

• Reduce acenocoumarol dose by 33% pre-emptively when starting metronidazole 1
• A 2020 study specifically on acenocoumarol showed metronidazole increased overanticoagulation risk 2.55-fold (HR 2.55; 95% CI 1.37-4.76) 3
• The FDA label explicitly warns that metronidazole "potentiates the anticoagulant effect of warfarin and other oral coumarin anticoagulants, resulting in prolongation of prothrombin time" 2

Monitor INR every 2-3 days during concurrent therapy and for one week after stopping metronidazole 1.

Ofloxacin (Fluoroquinolone): MODERATE RISK

Fluoroquinolones, including ofloxacin, can elevate INR and increase bleeding risk with acenocoumarol 1. While the evidence is stronger for ciprofloxacin (a CYP1A2 inhibitor), large national database studies confirm that fluoroquinolones as a class nearly double bleeding risk when combined with coumarins 1.

Management:

• Increase INR monitoring to every 3-5 days during ofloxacin therapy
• A 2019 study on levofloxacin (similar fluoroquinolone) with acenocoumarol showed mean INR increased from 2.5 to 4.7, with 54.3% reaching INR ≥4.5 4
• Consider 10-15% dose reduction if INR trends upward
• No pre-emptive dose reduction is recommended, but vigilant monitoring is essential

Ceftriaxone: NO DIRECT INTERACTION

Ceftriaxone does not have a pharmacokinetic interaction with acenocoumarol 5. The FDA label for ceftriaxone contains no warnings about coumarin interactions 5. Recent studies examining ceftriaxone use do not identify anticoagulant interactions as a concern 6.

Important Caveats:

• Like all antibiotics, ceftriaxone can alter gut flora and reduce vitamin K production, theoretically affecting anticoagulation 1
• Monitor INR weekly during any antibiotic course as standard practice
• No dose adjustment needed at initiation

Clinical Algorithm

When prescribing these antibiotics with acenocoumarol:

1. Metronidazole:

   • Reduce acenocoumarol by 33%
   • Check INR in 2-3 days, then every 2-3 days
   • Avoid if alternative antibiotics available

2. Ofloxacin:

   • No initial dose change
   • Check INR in 3-5 days, then twice weekly
   • Consider alternative if patient has bleeding risk factors

3. Ceftriaxone:

   • No dose adjustment
   • Check INR weekly (standard antibiotic monitoring)
   • Preferred choice when appropriate for infection

Critical Pitfalls to Avoid

• Never assume stability: Even "stable" patients on acenocoumarol can develop supratherapeutic INR when CYP2C9 inhibitors are added 1
• Don't wait for symptoms: Bleeding complications can occur before patient reports symptoms
• Remember the offset: After stopping metronidazole, increase acenocoumarol back gradually over 5-7 days while monitoring INR
• Document the plan: Ensure patient knows to report any bleeding signs immediately

The evidence clearly establishes metronidazole as the highest-risk combination requiring proactive management, while ceftriaxone represents the safest option among these three antibiotics 1, 3.